After months of courting U.S. drugmaker Genzyme, French pharmaceutical company Sanofi-Aventis launched a hostile bid valued at approximately $18.5 billion, or $69 a share, for all outstanding shares of Genzyme common stock.
Continue reading Sanofi-Aventis Launches Hostile Bid for Genzyme
Sanofi-Aventis Launches Hostile Bid for Genzyme originally appeared on DailyFinance on Mon, 04 Oct 2010 06:55:00.
Filed Under: Genzyme Corporation , Sanofi Aventis, Stocks in the News